# Nucleus Network: Advancing medicine, improving lives\. > Join Nucleus Network for advanced Phase I clinical trials across Brisbane, Melbourne, Minneapolis, and London, driving medical innovation globally\. Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Brisbane](https://www.nucleusnetwork.com/sponsors/global-network-advantage/brisbane/): Discover Brisbane's Nucleus Network, a leading hub for early\-phase vaccine and biologics trials, co\-located with Royal Brisbane and Women's Hospital\. - [Melbourne](https://www.nucleusnetwork.com/sponsors/global-network-advantage/melbourne/): Discover Australia's largest Phase 1 Clinical Trial Unit at Nucleus Network Melbourne, offering unmatched expertise and safety for early\-phase studies\. - [Sydney](https://www.nucleusnetwork.com/sponsors/global-network-advantage/sydney/): Discover Australia's largest Phase 1 Clinical Trial Unit at Nucleus Network Melbourne, offering unmatched expertise and safety for early\-phase studies\. - [Postmenopausal women](https://www.nucleusnetwork.com/c/postmenopausal-women/): Join clinical studies for postmenopausal women in Australia\. Contribute to medical advancements in a safe, supportive environment\. Check eligibility now\! - [Minneapolis](https://www.nucleusnetwork.com/sponsors/global-network-advantage/minneapolis/): Nucleus Network Minneapolis offers FDA\-aligned early\-phase trials with renal impairment expertise in Medical Alley, supporting global clinical programs\. ## Posts - [Dr Sally Dowen on curiosity, conviction, and becoming the leader she once needed ](https://www.nucleusnetwork.com/news/dr-sally-dowen-on-curiosity-conviction-and-becoming-the-leader-she-once-needed/) - [Nucleus Network Acquires Hammersmith Medicines Research](https://www.nucleusnetwork.com/news/nucleus-network-acquires-hammersmith-medicines-research/): Nucleus Network expands global reach by acquiring Hammersmith Medicines Research, enhancing clinical trial capabilities in Australia and the UK\. ## FAQ - [Is it safe to take part in a clinical trial?](https://www.nucleusnetwork.com/post-faq/is-it-safe-to-take-part-in-a-clinical-trial/) - [What is a clinical trial and why are people needed?](https://www.nucleusnetwork.com/post-faq/what-is-a-clinical-trial-and-why-are-people-needed/) - [Will I be paid for taking part?](https://www.nucleusnetwork.com/post-faq/will-i-be-paid-for-taking-part/) - [What happens if I change my mind or need to withdraw?](https://www.nucleusnetwork.com/post-faq/what-happens-if-i-change-my-mind-or-need-to-withdraw/) - [Will I get access to the treatment after the trial?](https://www.nucleusnetwork.com/post-faq/will-i-get-access-to-the-treatment-after-the-trial/) ## Resource - [Biotech innovation with Early\-Phase expertise](https://www.nucleusnetwork.com/post-resource/supporting-biotech-innovation-through-global-early-phase-expertise-with-dr-graham-wood/): Explore biotech innovation with Dr\. Graham Wood's global Early\-Phase expertise at Nucleus Network\. Discover cutting\-edge solutions today\. - [Aligning sponsor goals with participant\-focused trials](https://www.nucleusnetwork.com/post-resource/designing-trials-that-deliver-dr-graham-wood-on-aligning-sponsor-goals-with-participant-centred-science/): Explore Dr Graham Wood's insights on creating clinical trials that balance sponsor objectives with participant\-focused scientific approaches\. - [Clinical trials: Safety, process, and purpose](https://www.nucleusnetwork.com/post-resource/understanding-clinical-trials-safety-process-and-purpose/): Explore the safety measures, processes, and purposes of clinical trials in Australia\. Gain insights into participant protection and trial phases\. - [Safety by design: Trial integrity and volunteer](https://www.nucleusnetwork.com/post-resource/safety-by-design-our-approach-to-trial-integrity-and-volunteer-care/): Discover Nucleus Network's innovative approach to clinical trial integrity and volunteer care, prioritising safety and ethical standards\. - [Gap analysis and clinical services to strengthen your study design](https://www.nucleusnetwork.com/post-resource/gap-analysis-and-clinical-services-to-strengthen-your-study-design/): Enhance your study design with expert gap analysis and clinical services tailored for robust research outcomes in Australia\. ## Teams - [Dr Graham Wood](https://www.nucleusnetwork.com/post-team/dr-graham-wood/): Dr\. Graham Wood, Chief Scientific Officer at Nucleus Network, boasts 22\+ years in clinical pharmacology, leading over 2,000 studies globally\. - [Dr Jason Lickliter](https://www.nucleusnetwork.com/post-team/dr-jason-lickliter/): Dr\. Jason Lickliter leads Nucleus Network's Medical Dept\., specializing in early phase clinical trials and cancer research innovations\. - [Peggy North](https://www.nucleusnetwork.com/post-team/peggy-north/) - [Dr Philip Ryan](https://www.nucleusnetwork.com/post-team/dr-philip-ryan/): Dr\. Philip Ryan, Medical Director at Nucleus Network, leads Phase I clinical trials in neuroscience and healthcare with 20\+ years of expertise\. - [Chris Hickey](https://www.nucleusnetwork.com/post-team/chris-hickey/): Chris Hickey, Chief Business Development Officer at Nucleus Network, enhances global Phase I drug development with 16 years of industry expertise\. ## Trials - [The Autoimmune Research Study](https://www.nucleusnetwork.com/trial/the-autoimmune-research-study/): Join our Autoimmune Research Study in Brisbane to test a new treatment for inflammatory conditions\. Safe, monitored, and ethically approved\. - [The Hypopara Research Study](https://www.nucleusnetwork.com/trial/the-hypopara-research-study/): Join our clinical trial in Melbourne to explore a new treatment for hypoparathyroidism, aiming to improve calcium balance and quality of life\. - [The Kinase Study](https://www.nucleusnetwork.com/trial/the-kinase-study/): Join The Kinase Study in Minneapolis to explore drug interactions in healthy women aged 18\-55\. Apply now for this clinical trial opportunity\. - [The Parathyroid Health Study](https://www.nucleusnetwork.com/trial/the-parathyroid-health-study/) - [The Neuro Guard Study](https://www.nucleusnetwork.com/trial/the-neuro-guard-study/) ## Categories - [White Papers](https://www.nucleusnetwork.com/news/category/white-papers/) - [Media](https://www.nucleusnetwork.com/news/category/media/) - [Industry Events](https://www.nucleusnetwork.com/news/category/industry-events/) - [Expertise](https://www.nucleusnetwork.com/news/category/expertise/) - [Team Spotlight](https://www.nucleusnetwork.com/news/category/team-spotlight/) ## Resource Type - [Sponsor](https://www.nucleusnetwork.com/type-resource/sponsor/) - [Participant](https://www.nucleusnetwork.com/type-resource/participant/) ## Resource Category - [Trial](https://www.nucleusnetwork.com/cat-resource/trial/) - [Partnering](https://www.nucleusnetwork.com/cat-resource/partnering/) - [Testimonial](https://www.nucleusnetwork.com/cat-resource/testimonial/) - [About](https://www.nucleusnetwork.com/cat-resource/about/) - [Education](https://www.nucleusnetwork.com/cat-resource/education/) ## Resource Tag - [Trial](https://www.nucleusnetwork.com/tag-resource/trial/) - [Account](https://www.nucleusnetwork.com/tag-resource/account/) ## Optional - [Sitemap index](https://www.nucleusnetwork.com/sitemap_index.xml)